“(Aricept) helps a little bit with memory but it mainly improves the behaviour of the patient, things like aggression and depression, paranoia and asocial ...
Ranbaxy won tentative US approval to sell a generic version of Aricept, Eisai Co.'s Alzheimer's remedy, in the quarter. Aricept is the world's best-selling ...
... two weeks of treatment as a single therapy and separately in combination with donepezil, which is marketed by Eisai Inc. and Pfizer Inc. as Aricept. ...
... granted a tentative approval to Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) for a generic version of Eisai Co Ltd.'s Alzheimer's drug Aricept. ...
... New Drug Application (ANDA) to market its generic version of Eisai's Alzheimer’s treatment Aricept® (Donepezil Hydrochloride) Tablets, 5 mg and 10 mg. ...
s Aricept best- selling treatment for Alzheimer's disease. Teva expects final approval from the Food and Drug Administration around April 26, ...
T: Quote, Profile, Research) Alzheimer's drug Aricept. The branded product, which is co-marketed with Pfizer Inc. (PFE.N: Quote, Profile, Research), ...
all 29 news articles
... FDA for the its Abbreviated New Drug Application or ANDA to market the generic version of Eisai's Alzheimer's treatment Aricept Tablets, 5 mg and 10 mg. ...
... US Food and Drug Administration tentatively approved the company's abbreviated new-drug application to market a generic version of Aricept, Eisai Co. ...